Calian Group Ltd
TSX:CGY
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
42.88
61.19
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Earnings Call Analysis
Q4-2024 Analysis
Calian Group Ltd
Calian achieved a remarkable fiscal year 2024 (FY '24), marking their seventh consecutive year of record revenue growth. The company's revenue grew by 13%, totaling approximately $800 million, driven by a solid performance across all service segments. In addition to organic growth of 2%, significant contributions came from acquisitions, which accounted for 11% of revenue growth. The standout segments included Health and Global Defense, both showing robust performances despite some reductions in revenue from the Canadian Armed Forces.
Adjusted EBITDA surged by 30%, reaching $86 million, significantly outperforming revenue growth. The EBITDA margin reached an all-time high of 11.5%. This improvement reflects Calian's strategic focus on high-margin services and efficient cost management. The strong financial results also translated to a free cash flow increase of 29%, totaling $58 million, which represents a conversion rate of 68% from adjusted EBITDA. This financial discipline positions Calian for sustainable growth moving forward.
Calian completed three significant acquisitions throughout the year, investing nearly $90 million to bolster their service offerings. Notable among these was the acquisition of Decisive Group for $50 million, which has already shown annualized growth exceeding 25%. These acquisitions are not only expected to contribute to Calian's financial performance but also to enhance their capabilities, particularly in the defense and IT sectors, which are poised for continued expansion.
Despite overall growth, Calian faced headwinds within their Canadian defense segment, attributed to a reduction in training services for the armed forces. Nevertheless, leadership reflects that the performance is stabilizing with ongoing contracts, and potential opportunities for increased budgets exist, especially with U.S. and European defense spending trends. Calian management is optimistic about regaining momentum in this sector over the coming years.
Looking ahead to FY '25, Calian has provided guidance for revenue in the range of $800 million to $880 million, indicating continued double-digit growth for the eighth straight year. The adjusted EBITDA is expected to be between $96 million and $106 million, corresponding to an estimated growth of 12% and 10%, respectively. Key factors driving this outlook include a strong backlog of approximately $500 million and ongoing operational efficiencies, alongside strategic partnerships, notably with Microsoft and Walmart, to expand their market reach.
Calian is pursuing active globalization efforts, with international revenues now comprising 32% of their total. The strategy not only provides a robust framework for growth but also enhances brand recognition in the target markets. The integration of its various business units into cohesive solutions is positioned to differentiate Calian in competitive sectors, ranging from health care to defense.
Calian's financials remain robust, with total debt at $90 million and a net debt ratio of 0.4x, substantially below their target of 2.5x. The company has a liquidity reserve exceeding $200 million to support ongoing acquisitions and share buyback initiatives. Shareholder returns have been prioritized, with $13 million returned through dividends and share repurchases.
Going forward, Calian is shifting its narrative from siloed divisions to a unified solutions provider approach. This change reflects their capabilities to deliver integrated solutions tailored to customer needs, fostering opportunities across sectors like cybersecurity, healthcare, and defense. This strategy aims to maximize cross-selling opportunities and reinforce Calian's commitment to innovation.
Good morning, ladies and gentlemen. My name is Jennifer McCaughey, Director of Investor Relations at Calian. Thank you for joining us for Calian's Fiscal Year '24 Review and Management Update Video Webcast. With me this morning, live from Ottawa are Kevin Ford, Chief Executive Officer; and Patrick Houston, Chief Financial Officer. In today's presentation, we will review our fiscal year '24 results, and key achievements. We will also do a deeper dive of our recent strategic acquisitions and partnerships and conclude with our fiscal year '25 guidance and our plans to grow beyond $1 billion.
Before we begin, please take a moment to review the caution regarding forward-looking statements, which is now being displayed on your screen. A few housekeeping items to take note before we begin. This webcast is being recorded. [Operator Instructions] On that note, I will turn it over to Kevin.
Thank you, Jennifer. And I just want to give a few introductory remarks. First and foremost, welcome, everybody. It's our first time using this format, so we're looking forward to your feedback. But we thought it was important with our year-end, beginning of the new fiscal year to give you some thoughts on results, on strategy. So I really appreciate your time this morning. When I start with fiscal '24, clearly, from my viewpoint, a lot of positives here from the company, a very strong year.
We had another record revenue and adjusted EBITDA year, our seventh consecutive year of double-digit revenue growth. Our EBITDA growth surpassed our top line growth. New contract signings of $785 million and a healthy backlog of $1.2 billion. So again, very strong. And also, we've worked on our new -- 2 new presidents with Mike and Valerie joining the company, and they've been bringing new energies and thought process into the company. It's been exciting to see them join the company with such a vigor on growing their parts of the business.
On globalization, international revenues are now 32% of our total, and that's come a long way since I've got here. And clearly, a key part of our strategy is the globalization of Calian, and it's great to see those results demonstrate we're doing exactly that. On the acquisition front, coming off the Hawaii Pacific Teleport acquisition in August of '23, we've completed 3 acquisitions, and Patrick is going to talk to them, Decisive, the nuclear assets of MDA and Mabway. Investing close to $90 million in our M&A engine at attractive multiples and supported our innovation and diversification goals.
I'm also going to talk to some of the customers and partners that we're seeing and basically excited to be working with, Walmart and Microsoft, the Ottawa Senators, our sponsorship and partnership with the Ottawa Senators. Clearly, our goal is not only to deliver but to raise brand awareness in our target markets, and these are just some exciting announcements that I'll talk to a bit later in the podcast. So with that, I'm going to it turn over to Patrick to talk about our fiscal '24 results, and I'll come back with some comments on '24 and our strategy moving forward. Over to you, Patrick.
Thank you, Kevin, and good morning. As Kevin said, we're pleased to announce another record year for Calian, our seventh consecutive record year. Revenue increased 13%, driven by growth in all of our service offerings. Acquisition growth was strong this year at 11% with contributions from HPT, Decisive, the nuclear assets of MDA and Mabway. Strong organic growth in Health as well as growth in our Global Defense business was offset by reductions by the Canadian Armed Forces and our domestic training services.
Overall, organic growth was 2%, but would have been closer to our 5% target when isolating the impact of the Canadian Armed Forces dynamic. EBITDA growth was strong this year, increasing 30%, significantly outpacing our revenue growth. Margins ended at 11.5%. That's the highest level in company history. Free cash flow increased 29% to $58 million, excluding working capital. This represents a conversion rate of 68% from adjusted EBITDA.
Working capital dynamics continue to be positive this year. We recaptured $35 million in working capital and our efficiency improved from 14% last year to 7% in FY '24. We deploy capital across multiple initiatives. As Kevin mentioned, $90 million across 3 acquisitions this year. Our CapEx was approximately $12 million, mainly growth CapEx for our IT and space businesses. We returned $13 million to shareholders in the form of dividends, and we continue to buy back shares.
Last year, we purchased $6 million of shares, and we've continued to buy back shares in October and November. Adjusted EBITDA per share, operating free cash flow per share and adjusted EPS per share all up over 25% from last year and all represent a high level for Calian. We're able to do this by increasing gross margins, focusing on growing our more profitable businesses and remaining disciplined on our balance sheet.
Our balance sheet continues to be in a great position. Debt stood at $90 million and on a net debt basis, $38 million at the end of Q4. That's a leverage ratio of 0.4x, well below our target of 2.5x. And we have over $200 million of liquidity ready to deploy on both our M&A and buyback agendas. We completed 3 strategic acquisitions this year, which will contribute significantly to Calian in the coming years. Let's take a moment to look at those deals.
We acquired the Decisive Group in 2023 for a purchase price of $50 million. Our strategy is to be a local -- leading local provider in multiple key North American regions for cloud, cyber and IT solutions. The team at Decisive has been a trusted provider for a diverse set of clients with a particular focus in defense and security, a highly regulated market.
This is very synergistic with Calian's core business of serving defense and security customers with a host of solutions over the last 25 years. Decisive portfolio allowed us to round out our offering in the Ottawa and federal procurement market, a key growth driver for us in the coming years. The acquisition also brings enhanced scale to our overall IT business, which will provide superior economics for our existing U.S. and Canadian offerings.
Since acquiring Decisive, we've seen considerable revenue and EBITDA growth. Growth since the acquisition on an annualized basis surpassed 25%. Through existing contract vehicles and a strong sales and delivery team, they've been able to respond to growing demand from federal defense and security customers. Our government cloud offering will be a key differentiator as we support our customers on their ongoing transition to a secure sovereign solution, and we'll be leveraging the team as we push into the Canadian commercial market and bring Calian's differentiated IT solutions portfolio to key regions in North America.
Let's take a look at the deal we did with MDA earlier this year. We purchased their nuclear assets and we're able to add it to our existing nuclear consulting business, which has been growing consistently within Calian over the last 5 years. Nuclear power, a backbone of the Canadian electrical good has experienced significant tailwinds as various jurisdictions seek out ways to expand capacity while minimizing greenhouse gases. We quickly integrated the 2 groups and are now able to bring end-to-end solutions to our customers.
This includes safety analysis, environmental studies, system engineering and robotics to name just a few. We continue to expand the combined teams to meet growing demand from our customers. This team has also gotten off to a strong start, posting in excess of 25% EBITDA growth since the acquisition. We also announced earlier this year a considerable amount of new contracts with nuclear operators in provinces across Canada, which will ensure continued growth into FY '25.
We've also started to bring some of Calian's other assets to our nuclear customers. This includes integrating our market-leading GNSS antennas on our nuclear robotics solution to further enhance its capability as well as we kicked off our first project in virtual reality training by duplicating a nuclear power plant to be used to rehearse various procedures in the future.
I think this transaction highlights 3 key factors for Calian. The ability to pair an acquisition with an existing Calian business to accelerate the momentum integrate the business quickly to achieve better efficiencies and finally, capitalize on market trends and grow aggressively.
Let's take a look at our most recent acquisition, Mabway. This is our third acquisition outside Canada aimed at expanding our military training into the European continent. Mabway supports the U.K. Ministry of Defense in delivering large-scale role-playing environments, which supports real-world training. Following the acquisition, Calian is now one of the main training partners for Canada, the U.K. and NATO.
This includes training exercise delivered on a daily basis across the globe, but also a seat at the table as each of these groups develops their long-term defense strategies. The combination of Calian and Mabway has resulted in, again, a very strong start. Growth in demand and the team's ability to respond and deliver has resulted in strong financial growth. The urgency in Europe continues to increase due to the continuing conflict in Ukraine. Almost all European nations have announced increases in military spending and are making significant investments.
Training and operational readiness will be a key skill for these nations as they deploy across Europe, and this is where Calian's broad capabilities come in. To recap on M&A, 3 strategic assets that enhance our offerings across Canada and Europe became part of Calian this year. We acquired all of them at attractive prices. All 3 have grown significantly since becoming part of the broader Calian offering, and all 3 have significant growth tailwinds behind them for the coming years.
I'm now going to pass it back over to Kevin to speak about some partnerships we've recently announced.
Thank you, Patrick. This year, we signed 2 strategic partnerships with Microsoft and Walmart, 2 Fortune 100 companies. And it's demonstrating to me that our strategy is working. When a small-cap company is getting the attention of multibillion-dollar global companies, it shows we're on the right track from my viewpoint. And these partnerships are, in some ways, different in the context of one is a customer and one is a go-to-market partner. But the fact that they're working with Calian, I think, is a proud moment for the company.
We're working with them in mission-critical areas of health and cybersecurity. And it's a great example of our ability to cross-sell with regard to these customers and our go-to-market strategy. Clearly, it's going to help raise our brand awareness, which is a goal for us globally and provides building blocks for future growth as we look at strategic partnerships, a key element of our growth strategy. So let me take a moment to review look at and review each of these deals.
With Microsoft, and if Mike [ Drombleay ] was here, in many ways, I'm using his words so hello, Mike. Today, and Mike's vision is to basically ensure that we seek to be a trusted regional partner for cybersecurity, IT and cloud solutions in select North American markets. AI has become a key driver in the consolidation of fragmented markets and this is particularly true in the world of cybersecurity. Through our collaboration with Microsoft, Calian ITCS integrates Microsoft Sentinel and Copilot with our cybersecurity expertise to offer AI-enhanced predictive security solutions.
Our partnership with Microsoft significantly expands our service capabilities, allowing us to deliver end-to-end protection and enablement solutions that address complex challenges for our clients. And this collaboration with Microsoft is transformative, empowering us to leverage next-generation tools, particularly in AI and automation, which enables rapid market responsive solutions for our customers.
Through this partnership, we're broadening Calian's reach across high-growth, high-margin areas such as cloud, AI and security. And in hockey terms, we're going to where the puck is going. This diversification drives balanced growth and positions us as a comprehensive solutions provider capable of supporting clients across their entire digital journey. And the strategic bold move sets the stage for organic and acquisitive growth targets to become a regional market player in all the markets that we're targeting. So congrats to Mike and the team on this. We're very proud of this.
And again, we're just getting going with this relationship, and I'm happy to say it's off to a very strong start. With regard to our collaboration with the Walmart, the key element to me when I met with the team and the Walmart executives in their office in Toronto is that I was there as a CEO of the company, not representing just health, but our health care business, our training business, our cloud services, our infrastructure security monitoring, protecting.
And what we are able to do is knit the components of Calian into a comprehensive solution for our customer. This relationship will also provide visibility for Calian's Nexi platform as we go to market now with digital assets and what our anchor customer it is. And it clearly exemplifies our commitment to providing leading-edge health care solutions for organizations such as Walmart. So exciting.
I know we're just getting going on this. And frankly, from the team, I'm expecting big results in the sense of providing an opportunity to take our brand and our Nexi platform to new levels. With that, let me conclude on fiscal '24. Our fiscal '24 results are on track with our 2026 strategic plan. Revenues are up 13%, in line with 15% target growth rates. Our adjusted EBITDA, as Patrick mentioned, was up 30% or $20 million, on track with reaching $125 million and essentially doubling our adjusted EBITDA over 3 years.
Our M&A agenda is on track with 3 acquisitions completed, generating half of the annualized EBITDA targeted in our 3-year plan and a healthy pipeline exists for fiscal '25. We expect '25 to be another record-breaking year. And with that, I'm going to pass it to Patrick to talk about our guidance for fiscal '25.
Thank you, Kevin. Before I discuss FY '25 guidance, I'd like to mention that we'll be realigning the definition of our adjusted EBITDA going forward. In order to align with many of our peers and provide a more accurate comp in the market, we'll now be excluding the impact of stock compensation expense, as well as the onetime transaction costs related to our M&A agenda.
FY '24 adjusted EBITDA of $86 million would have been $92 million once adjusted. In the appendix of this presentation, we will be -- which will be posted on our website after the webcast. You'll find a reconciliation of the new and adjusted EBITDA for the past 5 years. Now turning over to fiscal 2025. We expect revenue guidance in the range of $800 million to $880 million. This represents double-digit growth again for the eighth consecutive year. Adjusted EBITDA guidance in the range of $96 million to $106 million. At the midpoint of the range, it would represent revenue and EBITDA growth of 12% and 10%, respectively.
We have a strong backlog of approximately $500 million entering this year with a diverse set of offerings and a strong pipeline. These numbers do not account for any additional acquisitions that may close in FY '25. We continue to be a consistent capital deployer and we expect to complete a few incremental transactions as we've been doing so over the last several years. Now back over to Kevin to close off this call with growing beyond $1 billion.
Thank you, Patrick. I often get asked the question about the $1 billion target that I put out there in the context of our one 2026 plan. And I want to be clear here. The $1 billion is not where we stop the company. The $1 billion is a target for our 3-year strategic plan. This is my third 3-year strategic plan since taking over as CEO of Calian. I'm a big fan of 3-year plans that holds us accountable to achieve the objectives we set out with our Board with regard to growing the company, growing the company the right way, not only from a financial perspective, but on the building blocks that will take this company not just to $1 billion, but to a multibillion-dollar company globally.
The key element to me is that, as I mentioned, this $1 billion is a goalpost. It's an objective. It's a milestone. And I believe that we have all the ingredients to continue to grow not just to $1 billion, but to a multibillion-dollar global company. Some of them are listed on this chart, and I'm going to talk to each one. First and foremost, our M&A engine. I think we're getting known as a good deployer of capital, a good acquirer. We're going to be announcing a new VP of Mergers and Acquisitions soon.
We're going to continue to strengthen that office, and we are going to continue to lean in on our M&A agenda because we believe it's working. It's helping us to innovate. It's helping us to diversify. And the companies we're bringing in are excellent. They're fantastic people with innovative solutions that's helping us differentiate Calian globally. I'll talk to our record of performance.
I'll talk to our tailwinds in our target markets, our revenue diversification and industry solutions. From a track record of performance, and I've said this many times, when I came to Calian, I'm not sure people viewed us as a growth company. I hope we're putting that to bed. I hope with continued results, as you see in this chart, double-digit growth over time, 7 years of consecutive debated growth, and our guidance puts us in another record year for our eighth consecutive year.
I'm hoping that people are excited by that. I am, and we are not a company that's talking about growing. We're a company that's growing and doing it the right way. The other thing that I have an inflection point because I think we are at an inflection point as a company, talking to our shareholders with regard to how does all this work, Kevin, the 4 segments.
And I think we've got to start talking about how we're organized as a company and how we're knitting together all those competencies that we have as a company to deliver exciting solutions for our customers. And tailwinds on our target markets, that we are focused on every day is clearly going to be a growth driver. And we got to start talking more about that. Defense and public safety, you look at the macro environment that exists today in the world. You look at the current U.S. election. You look at the state of our climate change, public safety initiatives. I think we're well positioned to continue to grow because we are and have been working in the sector for almost 30 years now.
In space programs, the space economy clearly is hot. I'm not sure we get the respect that we deserve, frankly, in the space economy, and I got to work on that. I got to work on that because this has been our Advanced Technologies group, and we got to make sure that we're highlighting the great work we're doing in space for almost 40 years now and the role that we play in the orchestration of space.
In cybersecurity, it's not often a company can say that something they do is relevant to every customer you talk to. Cybersecurity is probably in the top 1, 2, 3 priorities of any company or Board with regard to protection and how they actually expand their presence being safe and secure in a cyber world. This is exciting. The relationship with Microsoft, as I mentioned, Mike's vision, I'm very excited by this. And I think now we're going to see continued momentum in our cybersecurity business.
And then clearly, in healthcare, capacity challenges, just the reality of demand, aging population, not just in Canada but globally, who better than to take all of our capabilities and address that sector, which we have been growing consistently over the last couple of years. We expect to see continued growth in our targeted markets, and I'm excited to say that we're going to talk more about these going forward. In revenue diversification, one of the goals when I took over this company that we were primarily a Canadian company, primarily government.
Well, as you can see here, from an international perspective, our revenues continue to grow. We continue to take the company global. We now have a presence in the U.K., in Europe. We have a presence in the U.S. that's growing. I think that's critical to our long-term growth objectives, and we will continue to invest in our international globalization efforts.
One of the other goals was to continue to work with our incredible government customers, but also expand into our commercial markets to help us balance the ups and downs of those markets. And again, as you can see here, we're making great progress in expanding our presence in not just government globally, but also in commercial organizations. And the third one is really, I think, where we need to continue to highlight to our shareholders, to our customers is our product and innovation agenda.
As you can see here, we continue to grow our product revenue. We have more Calian products in the market. And we're also moving to take those products and knit them together into incredible solutions for our customers, bringing in together other components of Calian. I think this is going to be exciting footprint for us going forward. And again, we're going to talk more about this because, again, I'm not sure we're recognized as the innovative company that we are.
So diversifying revenue streams in higher-margin areas is what we've been trying to do, and that's exactly what we have done, as you can see by the results. This will be a key element of our growth going forward. Opportunities for more cross-selling. As I mentioned, we have to move away from talking about this company as 4 distinct separate segments and start talking about the unique opportunity Calian has to take those capabilities to customers and offer comprehensive solutions.
For example, in defense, we today provide cybersecurity, healthcare, military equipment manufacturing, training. I view this as an operational readiness solution. I'm going to say that again. I believe Calian has an operational readiness solution for militaries, both domestically and globally. There is no other company that can knit these things together and offer whether it's capacity for troops, training for troops as far as health care as well as providing engineering, manufacturing capabilities, cybersecurity, who does all of that? We do.
And we got to celebrate that and start positioning this as a solution, not the sum of its parts. In our Space business, same cybersecurity, training, software engineering, manufacturing, communication products. We have to quit talking about them as separate things and talking about our incredible solution that we can offer to a customer, an orchestration solution, something that basically differentiates in the space economy and Valerie now has a passion to do this with our team, so stand by on that.
In healthcare, same again, digital health services, cybersecurity, training cloud, IT, clinician services. I can go meet the CEO of a hospital and say, what's your pain point today? Is it data integration? Is it cyber? Is it capacity? Is it how you're basically looking at all of it? How many companies can go and have that discussion with the customer? Not many, and I'm proud to say Calian is doing exactly that. And if we look at our health care solutions, we have to start talking that way, not about the sum of the parts. So clearly, we're going to continue to focus on industry solutions. And I think in the future, you're going to hear me talking more about that in the company and how we go to market, not how we're organized.
That's the inflection point for this company right now for the markets. So moving forward, I believe we have a solid base to build and grow. We have a track record of performance. As I mentioned, we're not a company that's talking and hoping to become a growth company. We have been 7 years of record growth, 8 years on track. We have an M&A pipeline, I think that, frankly, is still strong.
Patrick is doing a great job running that office. We're going to invest in it. I'm looking forward to enhancing that VP of M&A to support Patrick and the team. And that's coming soon, but that's not stopping. The tailwinds in our growth markets, defense, health care, cyber space, I don't see that changing anytime soon. And frankly, we're uniquely positioned to take in all of Calian and differentiate ourselves globally on being able to be a trusted partner to customers when they cannot fail.
Revenue diversification, we will continue to go global. We will continue to move between commercial and international markets. We'll continue to look at government as a strategic partner. And I think again, when you look at our results, it's exactly what we've been doing. And I think the pivot point for us as a company, the inflection point is the last one, is that recognizing the solutions we're bringing to customers not as a 4-piston engine anymore, but as a cohesive company aligned to our growth markets.
All of this is backed by a strong financial position that we've built, earned. The team at Calian working hard has earned us and the trust of our shareholders. I'm confident this is an inflection point. And I think what you're going to see is some more exciting news from Calian as we move forward, as we inflect on how we go to market as a company. I'm going to pass that back to Jennifer.
Thank you very much, Kevin and Patrick. As I mentioned at the beginning, we will be taking questions from our analysts at this time. [Operator Instructions]
So I see that the first question is from Doug Taylor from Canaccord.
I'm going to ask a couple of questions on the guidance that you've provided this morning. The first question is about the Canadian defense budgetary pressures that you flagged now for a couple of quarters is impacting revenue across several segments, certainly learning. You referenced also the tailwinds in those areas.
So I guess my question I'd like to start with is about what sort of relief or catch up or any of that there is factored into your new guidance. And perhaps you can speak to your early take on the impact of some of the rhetoric we're hearing around defense spending from the incoming Trump administration and what that might have in terms of impact on your business?
Thanks, Doug. I think from -- let me start with Canada first. And where we saw the headwind, I think, last year was primarily in our learning business just on the pace of training. And our healthcare business was very strong. We're still seeing good engineering manufacturing mandates. So what I'm seeing right now from a Canadian perspective is a baselining.
We don't see discussion around further cuts. We see now the department working within the budget mandate they've been given and us having a clear mandate on basically our portfolio, whether it's on training and health care. So I'm not expecting it to get worse. I think they've stabilized. And now it's working with the customer within the budget envelope they've been given to grow so -- or to execute. So for now, unless there's a fundamental change in policy, I'm not expecting Canada to go into deeper budget cuts. And hopefully, now we can move forward with a stable budget working with our customer on training pace, healthcare pace, IT manufacturing pace as well.
On the global defense market, I'll start with that and then deal with the Trump administration as the last point. We still can see incredible urgency in Europe and NATO with regard to pace with regard to training mandates. We're seeing opportunities now across all of the European Union. Our presence now with Mabway, we see strong pace and demand on the U.K. training as well. So we expect Europe to continue to be a strong contributor for -- in context to our guidance, Doug, as well as the U.S. administration, and I'll leave on that.
We're not expecting that type of pressure to mean that folks are going to be considering less defense spending in certain areas for sure. We'll wait and see what that is. But in the past, Mr. Trump was clearly clear on his expectation on the 2% of GDP spending for NATO. And I don't think that's going to be subsiding in any sense in the short term. So if anything, it may solidify budgets and pace, I think, exists in Europe. And I believe Canada is now at a stable point where we can hopefully move forward here on a solid base for the year.
And so a follow-up question on that then. I mean, understanding the revenue guidance, I think, I believe suggests some optimism, at least at the midpoint towards the high end in organic growth rebounding quite a bit above the 5% target rate, if I'm not mistaken, certainly at the top end. In light of some tricky conditions you've had over the past couple of years, I guess my question here is, can you speak to your confidence interval in the guidance that you've laid out today? And what are the factors that separate the low end from the midpoint and high end of the range that we should consider?
Yes. Great question. And I'm cognizant, as you said, Doug, the areas -- the company's performance, I think, has been masked a bit by exactly what you're saying, just on the guidance and the expectations and making sure we're managing that. I'm reflective of that, inflective of that, if I can say it that way.
So I appreciate the question. From my viewpoint, we do a lot of work with our team on looking at all the factors as we set guidance at the beginning of the year, our budgets. Really, what it reflects is that I believe when I took over, I talked about a 5% organic growth posture. I believe we're well positioned this year. Again, if you took out some of the defense headwinds we had last year in learning, we would have been in that range. So I believe all the investment we're making continues to keep us in that 5% range. What goes up, what goes down?
Well, from my viewpoint, I think what we're seeing is some exciting opportunities in areas such as IT cyber. I think we're on a rebound for sure in there, especially with Mike's leadership and our relationship with Microsoft. As I mentioned, the Defense Canada spending, I believe, has stabilized. So any increase in that would help move our guidance up, if I can say it that way, but I'm also trying to be very conservative coming out of the blocks because we do not want to be a situation where we're getting ahead of ourselves and our analysts, frankly, on expectations and guidance this year.
So a lot of moving parts right now. I think we have opportunities across all of our business, and we're going to continue to model this, but optimistic, but trying to be conservative coming out of the blocks with regard to the realities we faced over the last couple of years on this exact issue of expectations and guidance.
That's helpful. One more quick one for me for Patrick, and I'll pass the line. Just so we can understand your -- the EBITDA guidance you're providing with some of the changes you're making in the definition, so we can understand that better. Can you speak to what, if any, acquisition or restructuring costs are baked into that guidance? Or is that 0 at this point. That would just help with the reconciliation.
Yes. We have some integration costs relating to the last 3 acquisitions we've done. I'd say it's in the $1 million to $2 million in the guidance. So that's been excluded out. Otherwise, the other costs will happen if we do transactions in the future and those will be removed.
Thank you, Doug. So next, I believe, is Scott Fletcher from CIBC.
I wanted to just stick with the guidance on the adjusted EBITDA side. You're sort of looking at year-over-year with the adjusted new definition of adjusted EBITDA looks like a little bit of margin compression. Could you maybe sort of speak to where that might be coming from on a segmented basis?
This year, and we're down to 11.2% to 3% in the guidance. I think we are certainly making some investments to try to capitalize on the growth initiatives that Kevin talked about, whether that's investing in more people in Europe to try to capitalize on that. So I think those are some of the short-term investments, but I think they'll pay off both this year, but in the year following with stronger organic growth. So I think it's very slight, but I think it's worthwhile investments for the long term.
Okay. And then I did want to sort of dig into something you mentioned near the end of the call where you talked about highlighting industry-specific solutions versus how you're organized. Are there any changes you need to make internally to sort of approach your sales process in that manner? Or is that already sort of done within the segments? Just curious from sort of an operational and organizational standpoint.
No. Great question, Scott. The inflection point, when I got here, we're a 2-division company, a 4-division company now. And an inflection point for me, especially over the last year, is just how much we've invested in products and technology and innovation and our pivot to solutions, innovative solutions. When I'm meeting with customers and we're talking about not how we're organized, but all the components we're bringing to customers, as I mentioned, I think it's an inflection point for the company.
So for us, your point is a good one because how do you operationalize that behavior? Well, this is where we're looking now with our sales organizations, our cross BU sales plans. So that basically that we ensure we're incenting that behavior with our go-to-market team. Let's quit talking about the company as one thing. Let's look at all the different capabilities we can get together for customers and solutions and then define the -- making sure we define those solutions, so it's clear, clear both to their customers, clear to our public markets.
And I think what you'll see over this year is us becoming very definitive on what those solutions look like. So I don't expect major organizational changes, but there is an operating rhythm that needs to be updated with regard to cross BU and also how we position ourselves as a solutions provider versus 4 distinct segments.
Thank you, Scott. So I believe the next one is Rob from Ventum.
So my question would be, I guess, a follow-on with respect to Doug's question with the Canadian defense spending. I understand where you're seeing a baseline. How quickly can that change? Like what would it take to get a change in momentum and the lag from declaration to actual commercial traction picking up?
Great question. I think what will change, there is a new -- I have to explain to a lot of people, the department went through a lot of things last year. They went through a major change in their executive leadership, right from the Chief of Defense Staff, Vice Chief, Canada Army. There was a lot of executive change to start. So that creates -- in any organization, that creates some moment where there's a pause, everyone takes a step back and looks at the mandate moving forward.
So I think now everyone is well into their positions. Everyone is very much clear on their mandates and what they're trying to get done. Second thing is, as we look at just the continued pace of what's going on in Europe and some of the tensions, I can't speak for the government. I have no idea of plans to increase defense spending. I'm not saying that in any way.
But I think if there was to be any relief on areas such as training, the good news is we have contract vehicles that can ingest that. That's not something we have to start with a new procurement. We have the ability to respond to that. And really now, it's going to be up to the government to decide at what pace they're going to continue to do things such as training.
So we're going to support them in those discussions. We're having those discussions today. And if there's a heightened readiness requirement, we're going to be ready. We're going to be ready. But I can't commit to that, Doug or Rob, sorry, because I just -- it's beyond our mandate to obviously talk about the defense budget. But right now, discussions are at least baselined. We know what we need to get done this year. And if there's an increase in posture with regard to spending, we'll be ready to go.
And as a follow-up, perhaps for Patrick. With respect to your M&A pipeline, can you talk to the composition or the mix of that pipeline in any way? And is it all impacted by this focus on providing solutions?
Yes, absolutely. We're looking at every M&A in terms of how does it enhance the solutions we have. So that's a big part of our screening criteria. So we're looking at every M&A through that lens and on top of the financial lens and the cultural lens. I think from a pipeline perspective, we've seen much more activity in health.
I think that's been a good sight to see after a very difficult environment to do good M&A at good value post COVID. So we're optimistic we can do a transaction in health this year. And we're continuing to see good pipeline. Like we've built a team now a process that can deploy $100 million a year on good M&A. I think we've proven we can do that, and we're expecting a similar outcome this year.
So team was busy last year. We did 3 transactions, all of them we highlighted on the call today. I think were excellent transactions, and now we're -- the team is ready to go do that again.
Thank you, Rob. So the next one would be Benoit from Desjardin.
Just to come back on organic growth. I was wondering if you could provide more details about the expected seasonality as we go through fiscal year '25. If I recall, Q1 last year, you started off the gate with 12% growth. So just wondering what about the cadence that we should be expecting? And if the midpoint assume kind of a 5% gentlemen?
I think from a cadence perspective, Benoit, we're happy to talk to that in the sense of our expectations from Q1, Q2, Q3, Q4. So let us take that offline with the analysts and just make sure everyone is in sync on our expected rates because we've mapped that out. And we want to make sure, again, as we talked about -- as I talked about, is not getting ahead of ourselves with regard to what is happening in each quarter and aligning on how we see this playing out this year.
With regard to the organic growth, as I mentioned, I think both the investment we made in M&A and what we're seeing with, again, things like Microsoft, our Nuclear Group, our space business, our defense business, we're cognizant and confident that basically those markets that we're serving are organic growth markets, and we should be taking our role in those. So I think 5% is achievable. We just got to make sure we stick to our knitting with our execution plan.
So happy to discuss offline. Jen will work with our analysts to make sure one understands how this looks like from our perspective from a road map perspective -- from a road map viewpoint right now, but we are confident in our ability to continue on our organic growth posture this year for sure.
Okay. And yesterday, there was a big announcement about the tariff that are looking to be implemented in Canada and Mexico. Just wondering if you could point out your exposure about the stuff that moves in the U.S. that could be impacted by some potential tariff at one point.
Patrick, do you want to take that?
Yes, the majority of our revenue, Benoit, in the U.S. right now is being done from the U.S. So our -- the investments we made in acquisitions in the U.S. has given us a platform to deliver there. So I think we do have some revenue that comes exported from Canada to the U.S., but it's a small portion. So I think we'll continue to look at how we use the M&A agenda to invest and get base in U.S. and I think that will help us kind of avoid any of the issues with tariffs.
Thank you. And the next question is from Paul. Right now, it looks like our last question. If the analysts have any follow-up, please raise your hand so I can see it. Thank you. Please go ahead, Paul.
Just a question on backlog coverage relative to guidance. I didn't see a disclosure in the MD&A, but it does look like that the coverage is better than last year. Just hoping you could comment on what you're seeing with backlog and the visibility that gives you to the upcoming year.
Yes. So we're entering the year with almost $500 million, Paul, of revenue that's booked. We had a really strong year in signings. We think $785 million in signings this year as well as when we brought on Mabway, we got good backlog coverage as well. So I think good basis there. I think the coverage, to your point, is a bit better than we were last year. So I think that gives us some confidence going into the year. And then the pipeline and the sales team is how we get to the organic growth and the number we put in the guidance.
Okay. And then looking at the revenue from the Canadian government, the disclosure in the MD&A includes all 3 levels and the revenue there rose year-over-year despite some of the headwinds that you've seen on the learning side. Can you speak to the drivers of the total revenue growth across all 3 levels of government, in particular, which segments are driving that and then also which levels of government are seeing the most growth?
Health was probably the strongest. I mean, double-digit organic growth this year that included defense, where we're continuing to see increased demand. It includes provincial governments as well as federal agencies. So really strong performance from the health team really knocked out part this year with double-digit organic growth, primarily with government. So I think they were probably the strongest driver of that growth, Paul.
Thank you, Paul. I don't see any other hands raised. Any analysts have any follow-up questions? No. Okay. So thank you very much, everyone, for attending. I please remind you to provide us with your feedback by clicking on the survey link. And with that, we will be speaking to you at our next quarterly call. Thank you so much.
Thanks, everyone, for joining us. We look forward to keeping you updated as we move through the year. Thanks again for your time this morning.